source
- Trump announces drug pricing deal with Regeneron, completing White House's 17-deal targetPresident Trump announced a drug‑pricing agreement with Regeneron Pharmaceuticals, marking the final deal in the administration's goal of securing 17 pricing arrangements. The agreement is intende…
- Sanofi's multiple sclerosis drug, previously rejected by FDA, receives positive recommendation from European regulatorsSanofi's multiple sclerosis drug, which the U.S. FDA turned down late last year, has now been reviewed by European authorities. The European regulators issued a positive recommendation today, sugg…